MLN Connects® Newsletter for Thursday, July 22, 2021
COVID-19: EUA for Tocilizumab Monoclonal Antibody Product
View this edition as a: Webpage | PDF
News
- COVID-19: EUA for Tocilizumab Monoclonal Antibody Product
- Medicare Ground Ambulance Data Collection System FAQs
- Wound Debridement: Comparative Billing Report in July
- 3 Ways to Protect Your Medicare Enrollment Information
- Americans with Disabilities Act: 31st Anniversary
- Viral Hepatitis: Medicare Covers Preventive Services
Compliance
- Polysomnography Services: Bill Correctly
Claims, Pricers & Codes
- ICD-10-CM Diagnosis Code Files for FY 2022
MLN Matters® Articles
- Changes to the Laboratory National Coverage Determination (NCD) Edit Software for October 2021
- Implement Operating Rules - Phase III Electronic Remittance Advice (ERA) Electronic Funds Transfer (EFT): Committee on Operating Rules for Information Exchange (CORE) 360 Uniform Use of Claim Adjustment Reason Codes (CARC), Remittance Advice Remark Codes (RARC) and Claim Adjustment Group Code (CAGC) Rule - Update from Council for Affordable Quality Healthcare (CAQH) CORE
- October 2021 Quarterly Average Sales Price (ASP) Medicare Part B Drug Pricing Files and Revisions to Prior Quarterly Pricing Files
- Quarterly Update to the National Correct Coding Initiative (NCCI) Procedure-to-Procedure (PTP) Edits, Version 27.3, Effective October 1, 2021
- Section 50 in Chapter 30 of Publication (Pub.) 100-04 Manual Updates
- National Coverage Determination (NCD 110.24): Chimeric Antigen Receptor (CAR) T-cell Therapy — Revised
Publications
- Critical Access Hospital — Revised
- Medicare Advance Written Notices of Noncoverage — Revised
- Rural Health Clinic — Revised
Multimedia
- Combating Medicare Parts C and D Fraud, Waste, and Abuse Web-Based Training — Revised
Posted 7/21/2021